Mirum Pharmaceuticals, Inc.·4

Mar 19, 5:40 PM ET

Howe Jolanda 4

4 · Mirum Pharmaceuticals, Inc. · Filed Mar 19, 2025

Insider Transaction Report

Form 4
Period: 2025-03-18
Howe Jolanda
SVP, GLOBAL CONTROLLER
Transactions
  • Sale

    Common Stock

    2025-03-18$44.45/sh2,415$107,3432,426 total
Footnotes (2)
  • [F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 16, 2024.
  • [F2]The weighted average sale price for the transaction reported was $44.448421, and the range of prices were between $44.21 and $44.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.

Documents

1 file
  • 4
    form4-03192025_090306.xmlPrimary